Skip to main content

Table 4 Clinical data for second-stage reimplantation. Numbers indicate median (25th–75th percentile)

From: The use of cell salvage during second-stage reimplantation for the treatment of chronic hip periprosthetic joint infection: a retrospective cohort study

Viable Cell salvage reinfused group Control group P-value
(n = 61) (n = 64)
Hemoglobin (g/l)
 Preoperative 137 (130–142) 136 (131–143) .694a
 Day 1 108 (99–117) 105 (94–112) .112a
Hematocrit (%)
 Preoperative 41 (40–42) 41 (39–43) .919a
 Day 1 32 (27–35) 32 (28–35) .804a
Estimated blood loss (ml) 846 (623–1230) 1195 (861 to 1474) .002a
Reinfused blood (ml) 300 (200–750)  
Allogeneic RBC transfused (units) 2.0 (1.5–2.0) 1.5 (1.5–2.0) .630a
Allogeneic RBC transfused, n (%) 7 (11.5%) 17 (26.6%) .041b
Plasma transfused (ml) 300 (163–1712) 200 (200–400) .896a
Plasma transfused, n (%) 4 (6.6%) 5 (7.8%) 1.000b
Duration of operation (min) 159 (143–180) 156 (130–175) .128a
Length of hospitalization (days) 11 (9–14) 12 (10–18) .045a
  1. aThe Mann–Whitney U test
  2. bThe Fisher exact test